Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oropharyngeal Neoplasms | 25 | 2024 | 491 | 6.720 |
Why?
|
Papillomavirus Infections | 28 | 2024 | 1610 | 5.700 |
Why?
|
Head and Neck Neoplasms | 27 | 2024 | 2891 | 5.250 |
Why?
|
Papillomaviridae | 15 | 2024 | 1119 | 2.530 |
Why?
|
Carcinoma, Squamous Cell | 19 | 2024 | 4022 | 2.520 |
Why?
|
Alphapapillomavirus | 4 | 2022 | 218 | 1.950 |
Why?
|
DNA, Viral | 11 | 2024 | 2201 | 1.380 |
Why?
|
Free Tissue Flaps | 3 | 2024 | 331 | 1.330 |
Why?
|
Salivary Gland Neoplasms | 4 | 2016 | 304 | 0.970 |
Why?
|
Carcinoma, Adenoid Cystic | 3 | 2016 | 262 | 0.950 |
Why?
|
Receptor, Notch1 | 2 | 2018 | 496 | 0.890 |
Why?
|
Human papillomavirus 16 | 5 | 2023 | 267 | 0.810 |
Why?
|
Oncogene Proteins, Viral | 2 | 2023 | 340 | 0.790 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2022 | 101 | 0.770 |
Why?
|
Nasolacrimal Duct | 1 | 2022 | 79 | 0.750 |
Why?
|
Tonsillar Neoplasms | 1 | 2021 | 50 | 0.750 |
Why?
|
Sexual Behavior | 3 | 2018 | 2179 | 0.570 |
Why?
|
Electric Power Supplies | 1 | 2018 | 97 | 0.570 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2016 | 1605 | 0.570 |
Why?
|
NFI Transcription Factors | 1 | 2016 | 42 | 0.530 |
Why?
|
Foreign-Body Migration | 1 | 2018 | 219 | 0.520 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2024 | 9275 | 0.510 |
Why?
|
Thoracic Neoplasms | 1 | 2018 | 266 | 0.510 |
Why?
|
Scalp | 1 | 2018 | 389 | 0.480 |
Why?
|
Age Factors | 8 | 2021 | 18401 | 0.450 |
Why?
|
Mouth Neoplasms | 4 | 2024 | 596 | 0.450 |
Why?
|
Middle Ear Ventilation | 1 | 2014 | 101 | 0.440 |
Why?
|
Epidemics | 2 | 2018 | 511 | 0.440 |
Why?
|
Gene Rearrangement | 2 | 2016 | 1125 | 0.430 |
Why?
|
Cochlear Implants | 1 | 2018 | 339 | 0.430 |
Why?
|
Mouth | 1 | 2015 | 380 | 0.420 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1135 | 0.400 |
Why?
|
Otitis Media | 1 | 2014 | 287 | 0.400 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2421 | 0.390 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 781 | 0.380 |
Why?
|
Neoplasm Staging | 8 | 2024 | 11098 | 0.370 |
Why?
|
Prognosis | 16 | 2024 | 29588 | 0.370 |
Why?
|
DNA, Neoplasm | 2 | 2015 | 1745 | 0.360 |
Why?
|
Middle Aged | 41 | 2024 | 220774 | 0.350 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1393 | 0.350 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1737 | 0.340 |
Why?
|
Carcinoma | 2 | 2018 | 2328 | 0.290 |
Why?
|
Aged | 31 | 2024 | 169179 | 0.290 |
Why?
|
Humans | 61 | 2024 | 761326 | 0.280 |
Why?
|
Male | 45 | 2024 | 360621 | 0.270 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3448 | 0.270 |
Why?
|
Smoking Cessation | 1 | 2018 | 2056 | 0.260 |
Why?
|
Aged, 80 and over | 14 | 2024 | 58946 | 0.250 |
Why?
|
Retrospective Studies | 27 | 2024 | 80575 | 0.250 |
Why?
|
Female | 43 | 2024 | 392485 | 0.240 |
Why?
|
Cutaneous Fistula | 1 | 2014 | 79 | 0.230 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3801 | 0.230 |
Why?
|
Umbilicus | 1 | 2013 | 36 | 0.220 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 2019 | 0.220 |
Why?
|
Pharyngeal Diseases | 1 | 2014 | 134 | 0.220 |
Why?
|
Fistula | 1 | 2014 | 212 | 0.210 |
Why?
|
Osteoradionecrosis | 1 | 2022 | 51 | 0.210 |
Why?
|
Laryngectomy | 1 | 2014 | 243 | 0.210 |
Why?
|
Maryland | 3 | 2018 | 277 | 0.200 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2823 | 0.190 |
Why?
|
Laparotomy | 1 | 2013 | 457 | 0.190 |
Why?
|
Laryngeal Diseases | 1 | 2014 | 243 | 0.190 |
Why?
|
Parathyroid Hormone | 2 | 2018 | 1802 | 0.190 |
Why?
|
Palatine Tonsil | 1 | 2021 | 193 | 0.180 |
Why?
|
Risk Factors | 13 | 2021 | 74152 | 0.180 |
Why?
|
Minnesota | 1 | 2020 | 339 | 0.170 |
Why?
|
DNA | 2 | 2023 | 7216 | 0.160 |
Why?
|
Cleavage And Polyadenylation Specificity Factor | 1 | 2008 | 16 | 0.160 |
Why?
|
RNA 3' End Processing | 1 | 2008 | 16 | 0.160 |
Why?
|
Pain Measurement | 2 | 2020 | 3552 | 0.160 |
Why?
|
Tongue | 1 | 2021 | 403 | 0.150 |
Why?
|
Baltimore | 1 | 2018 | 231 | 0.150 |
Why?
|
Cicatrix | 1 | 2013 | 798 | 0.150 |
Why?
|
Disease-Free Survival | 3 | 2021 | 6815 | 0.140 |
Why?
|
Triage | 1 | 2024 | 986 | 0.140 |
Why?
|
Cohort Studies | 5 | 2024 | 41440 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2024 | 978 | 0.140 |
Why?
|
Otolaryngology | 1 | 2024 | 693 | 0.140 |
Why?
|
Mutation | 3 | 2018 | 30044 | 0.140 |
Why?
|
Qualitative Research | 2 | 2024 | 3025 | 0.140 |
Why?
|
Parathyroidectomy | 1 | 2018 | 242 | 0.130 |
Why?
|
Incidence | 7 | 2018 | 21336 | 0.130 |
Why?
|
Parathyroid Glands | 1 | 2018 | 518 | 0.130 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2018 | 163 | 0.130 |
Why?
|
Hypocalcemia | 1 | 2017 | 199 | 0.130 |
Why?
|
Salvage Therapy | 2 | 2021 | 1264 | 0.130 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7439 | 0.130 |
Why?
|
Endonucleases | 1 | 2008 | 369 | 0.130 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2022 | 801 | 0.130 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2015 | 89 | 0.120 |
Why?
|
Conserved Sequence | 1 | 2008 | 1164 | 0.120 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 462 | 0.120 |
Why?
|
Polymerase Chain Reaction | 1 | 2024 | 6086 | 0.120 |
Why?
|
Protein Subunits | 1 | 2008 | 942 | 0.120 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26108 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2018 | 272 | 0.120 |
Why?
|
Perimenopause | 1 | 2016 | 142 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 1 | 2022 | 1007 | 0.120 |
Why?
|
Calcium | 2 | 2018 | 5726 | 0.120 |
Why?
|
Seroepidemiologic Studies | 1 | 2016 | 397 | 0.120 |
Why?
|
Otoscopy | 1 | 2014 | 40 | 0.120 |
Why?
|
Chloride Channels | 1 | 2015 | 221 | 0.120 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 292 | 0.120 |
Why?
|
Adult | 21 | 2024 | 221122 | 0.120 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2017 | 290 | 0.120 |
Why?
|
SEER Program | 2 | 2016 | 1449 | 0.110 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1728 | 0.110 |
Why?
|
Otitis Media with Effusion | 1 | 2014 | 115 | 0.110 |
Why?
|
Laryngeal Neoplasms | 1 | 2017 | 514 | 0.110 |
Why?
|
Device Removal | 1 | 2018 | 630 | 0.100 |
Why?
|
Laryngoscopy | 1 | 2018 | 706 | 0.100 |
Why?
|
Postoperative Complications | 3 | 2021 | 15647 | 0.100 |
Why?
|
RNA, Messenger | 2 | 2016 | 12787 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2018 | 941 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1704 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39108 | 0.100 |
Why?
|
Thyroidectomy | 1 | 2017 | 907 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6473 | 0.100 |
Why?
|
Disabled Persons | 1 | 2021 | 1225 | 0.100 |
Why?
|
Thyroid Gland | 1 | 2018 | 1168 | 0.100 |
Why?
|
Referral and Consultation | 1 | 2024 | 3597 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2016 | 743 | 0.090 |
Why?
|
Survival Analysis | 3 | 2018 | 10075 | 0.090 |
Why?
|
Saliva | 1 | 2015 | 827 | 0.090 |
Why?
|
Counseling | 1 | 2018 | 1546 | 0.090 |
Why?
|
Epigenomics | 1 | 2015 | 941 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3204 | 0.080 |
Why?
|
Preventive Health Services | 1 | 2014 | 567 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2578 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2494 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2509 | 0.080 |
Why?
|
Quality of Life | 2 | 2024 | 13355 | 0.080 |
Why?
|
Sex Factors | 5 | 2018 | 10551 | 0.080 |
Why?
|
Pilot Projects | 2 | 2021 | 8632 | 0.080 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 662 | 0.080 |
Why?
|
Histones | 1 | 2008 | 2579 | 0.070 |
Why?
|
United States | 6 | 2018 | 72317 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7824 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12450 | 0.070 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11070 | 0.070 |
Why?
|
Prevalence | 4 | 2018 | 15719 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2023 | 15262 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3588 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2022 | 22124 | 0.070 |
Why?
|
Recurrence | 2 | 2018 | 8470 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12972 | 0.060 |
Why?
|
Risk Assessment | 3 | 2018 | 23981 | 0.060 |
Why?
|
Prospective Studies | 2 | 2023 | 54405 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2370 | 0.060 |
Why?
|
DNA Methylation | 2 | 2016 | 4383 | 0.060 |
Why?
|
Survival Rate | 2 | 2019 | 12710 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 64645 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4740 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5820 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2911 | 0.060 |
Why?
|
Correspondence as Topic | 1 | 2024 | 35 | 0.060 |
Why?
|
Adolescent | 4 | 2023 | 88305 | 0.060 |
Why?
|
Signal Transduction | 2 | 2018 | 23427 | 0.060 |
Why?
|
Internship and Residency | 1 | 2024 | 5877 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7238 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2504 | 0.060 |
Why?
|
Leukoplakia, Oral | 1 | 2024 | 77 | 0.050 |
Why?
|
Parotid Gland | 1 | 2022 | 175 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10715 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11735 | 0.040 |
Why?
|
Time Factors | 3 | 2018 | 39974 | 0.040 |
Why?
|
Tracheostomy | 1 | 2014 | 426 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9414 | 0.040 |
Why?
|
Organs at Risk | 1 | 2022 | 359 | 0.040 |
Why?
|
Suture Techniques | 1 | 2013 | 771 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20555 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13500 | 0.040 |
Why?
|
Hemoglobins | 1 | 2014 | 1524 | 0.040 |
Why?
|
Immunotherapy | 2 | 2024 | 4649 | 0.040 |
Why?
|
Medicare | 1 | 2016 | 6758 | 0.040 |
Why?
|
Infant | 2 | 2014 | 36202 | 0.040 |
Why?
|
RNA Precursors | 1 | 2008 | 212 | 0.040 |
Why?
|
Child, Preschool | 2 | 2014 | 42251 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2017 | 109 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7389 | 0.030 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2018 | 143 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2024 | 2696 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15835 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2008 | 931 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2014 | 1671 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2022 | 2898 | 0.030 |
Why?
|
Salivary Glands | 1 | 2016 | 229 | 0.030 |
Why?
|
California | 1 | 2018 | 1426 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 696 | 0.030 |
Why?
|
Vocal Cords | 1 | 2018 | 522 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4908 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2022 | 1958 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2022 | 1661 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2008 | 3592 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 59196 | 0.030 |
Why?
|
HeLa Cells | 1 | 2008 | 3097 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1900 | 0.020 |
Why?
|
Child | 2 | 2014 | 80156 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3792 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3469 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2914 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2281 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3873 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1703 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2880 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3335 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2853 | 0.020 |
Why?
|
Comorbidity | 1 | 2014 | 10498 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3572 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6341 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3438 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2760 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3590 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6422 | 0.020 |
Why?
|
Base Sequence | 1 | 2008 | 12449 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8526 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13446 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2985 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17640 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5778 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20092 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12059 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 15599 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14665 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7954 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8527 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16966 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81474 | 0.010 |
Why?
|
Animals | 1 | 2016 | 168388 | 0.000 |
Why?
|